Patents by Inventor Thomas Deuel

Thomas Deuel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulation of pleiotrophin signaling by receptor-type protein tyrosine phosphatase beta/zeta
    Patent number: 7056692
    Abstract: The mechanism by which pleiotrophin binds to the receptor protein tyrosine phosphatase ?/?(RPTP ?/?) is disclosed along with methods of modulating both pleiotrophin expression and signaling to treat, prevent and inhibit abnormal cell growth states. Specifically provided are methods of inhibiting tumor growth, promotion, metastasis, invasiveness and angiogenesis as well as methods of preventing or inhibiting cell adhesion.
    Type: Grant
    Filed: February 28, 2001
    Date of Patent: June 6, 2006
    Assignee: Barnes-Jewish Hospital
    Inventor: Thomas Deuel
  • Modulation of pleiotrophin signaling by receptor-type protein tyrosine phosphatase beta/
    Publication number: 20040014162
    Abstract: The mechanism by which pleiotrophin binds to the receptor protein tyrosine phosphatase &bgr;/&zgr; (RPTP &bgr;/&zgr;) is disclosed along with methods of modulating both pleiotrophin expression and signaling to treat, prevent and inhibit abnormal cell growth states. Specifically provided are methods of inhibiting tumor growth, promotion, metastasis, invasiveness and angiogenesis as well as methods of preventing or inhibiting cell adhesion.
    Type: Application
    Filed: January 23, 2003
    Publication date: January 22, 2004
    Inventor: Thomas Deuel